Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 141.30 4.40
Tata Mot 428.65 4.24
Bhel 181.05 3.10
Tata Stl 418.80 1.22
Ntpc Ltd 123.05 0.37
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-American Remedies Limited
American Remedies Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:31534NSE:NABloomberg:AMRR@INReuters:AMRL.BO
Market Lot: Face Value: 10ISIN Demat: INE315A01014
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Business
of American Remedies is wide range of pharmaceutical formulations.American Remedies Limited (ARL) was established as a sole proprietary concern in 1976 by R K Ramanthan. It was incorporated to a private limited company in 1986 and converted to a public limited company in 1990. Dalton laboratories and Chem Innova Pvt Limited were amalgamated with ARL. In the FY 2000, Dr Reddy`s laboratories Limited has acquired the entire stake of the promoters ...   More..
Future Plans
One To One
Recent news
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2001 (12)31-Mar-2000 (12)31-Mar-1999 (12)
Net sales 848.18942.90868.89
Other Income13.913.704.80
Total Income862.09946.60873.69
Cost of goods sold665.52978.20762.30
OPBDIT196.57-31.60111.39
PAT97.39-117.7012.13
Gross Block--356.46
Equity capital52.650.0052.65
EPS (Rs.)0.000.002.30
DPS (Rs.)--2.00
BV (Rs.)--33.08
P/E range (x)NANA12.61 - 34.85
Debt / Equity (x)--1.77
Operating margin (% of OI)22.8-3.312.7
Net margin (% of OI)11.3-12.4 1.4
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
14, Lattice Bridge Road
Adyar
Chennai
Tamil Nadu-600 020
PHONE
- - -
FAX
- - -
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer